Table 1

Participant baseline characteristics

VariableILF-NF + TAU*
n = 46
TAU only*
n = 47
Age, yr39.6 ± 12.636 ± 11.8
Male30 (65)31 (66)
Education level
 Primary school or less18 (39)24 (51)
 High school21 (46)16 (34)
 Bachelor’s degree or higher5 (11)5 (11)
Living alone22 (48)24 (51)
Problematic substance use, yr9.2 ± 8.29.9 ± 8.7
Working days in the past 30 d3.5 ± 6.83.7 ± 9.2
EuropASI score
 Alcohol use0.15 ± 0.190.14 ± 0.19
 Drug use0.04 ± 0.10.04 ± 0.1
Mental distress§2.39 ± 0.522.47 ± 0.67
Sleep quality4.1 ± 2.33.9 ± 3.0
Restlessness5.5 ± 2.26.4 ± 1.8
Obsessive thinking6.6 ± 2.36.7 ± 2.8
Perceived functioning**20.0 ± 8.419.2 ± 8.8
QoL-5 score††0.51 ± 0.130.50 ± 0.16
  • EuropASI = Addiction Severity Index, European version; ILF-NF = infralow frequency neurofeedback; TAU = treatment as usual.

  • * Data are presented as n (%) or mean ± standard deviation.

  • Problematic use of major drug(s) of abuse, as defined in EuropASI, was the consumption of 5 or more standard drinks at least 3 times weekly, or binge drinking on 2 consecutive days to a level that afflicted daily functioning.

  • Measures substance use severity using a composite score of 0 (no problem) to 1 (severe problem).

  • § Measured using the Hopkins Symptom Check List 10 (SCL-10). Responses are scored on a 4-point scale of 1 to 4 and averaged to a global severity index; a higher score indicates higher distress.

  • Measured using 10 cm visual analogue scales. The sleep quality scale ranged from “poor” to “good,” and the restlessness and obsessive thinking scales ranged from “none” to “very high.”

  • ** Measured using the Outcome Rating Scale; scores range from 0 to 40, and higher scores indicate better functioning.

  • †† Measured using the QoL-5 scale, ranging from 0.1 to 0.9, where 0.9 is the highest or best score.